T1	Participants 90 123	advanced nasopharyngeal carcinoma
T2	Participants 273 317	patients with nasopharyngeal carcinoma (NPC)
T3	Participants 410 430	42 patients with NPC
T4	Participants 468 488	40 patients with NPC
T5	Participants 1705 1722	patients with NPC
